NCT00004288View on ClinicalTrials.gov

Phase II Pilot Study of Olsalazine for Ankylosing Spondylitis

PHASE2CompletedINTERVENTIONAL

Enrollment

4

Participants

Timeline

Start Date

May 31, 1996

Study Completion Date

December 31, 1999

Conditions

Ankylosing Spondylitis

Interventions

DRUG

olsalazine

All Listed Sponsors

collaborator

University of Rochester

OTHER

lead

National Center for Research Resources (NCRR)

NIH

NCT00004288 - Phase II Pilot Study of Olsalazine for Ankylosing Spondylitis | Biotech Hunter | Biotech Hunter